This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Business / Context Therapeutics announces...
Business corporate announcement

Context Therapeutics announces conference presentation, stock options

Analysis based on 7 articles · First reported May 27, 2026 · Last updated May 27, 2026

Sentiment
10
Attention
2
Articles
7
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The announcement of Knight Therapeutics' presentation at the Jefferies Global Healthcare Conference could increase investor awareness and potentially lead to a positive short-term impact on Knight Therapeutics' stock price. The stock option grant to a new employee is a standard practice for employee retention and recruitment, which may have a minor positive impact on Knight Therapeutics' long-term operational stability.

biopharmaceutical
Event Summary

Knight Therapeutics Inc. announced its upcoming presentation at the Jefferies Global Healthcare Conference in New York on June 3, 2026. A live webcast of the presentation will be available on the company's website. Additionally, Knight Therapeutics granted a non-qualified stock option award to a new employee for 146,000 shares of its common stock, with an exercise price of $2.63 per share. These options have a 10-year term and vest over four years, in accordance with Nasdaq-100 Listing Rule 5635(c)(4). Knight Therapeutics is a clinical-stage biopharmaceutical company focused on T cell engaging bispecific antibodies for solid tumors.

Entities Involved
stock
Knight Therapeutics
Knight Therapeutics announced its presentation at the Jefferies Global Healthcare Conference and granted stock options to a new employee, which could positively impact its visibility and employee retention.
Importance 100.0 Sentiment 10.0
stock
Mizuho Financial Group
Mizuho Financial Group is hosting the Global Healthcare Conference where Knight Therapeutics will present, providing a platform for the company to gain investor attention.
Importance 40.0 Sentiment 0.0
index
Nasdaq-100
Nasdaq-100 is mentioned as the exchange where Knight Therapeutics' stock is listed and where its closing price was reported for the stock option grant.
Importance 20.0 Sentiment 0.0
govactor
United States — United States Securities and Exchange Commission
The United States — United States Securities and Exchange Commission is referenced as the recipient of Knight Therapeutics' filings, including its Annual Report on Form 10-K.
Importance 10.0 Sentiment 0.0
Relationships
Mizuho Financial Group related ↔ Nasdaq-100
Mizuho Financial Group related ↔ United States — United States Securities and Exchange Commission
Nasdaq-100 related ↔ United States — United States Securities and Exchange Commission
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.